TARSTarsus PharmaceuticalsTARS info
$32.55info4.83%24h
Global rank7504
Market cap$1.08B
Change 7d18.19%
YTD Performance62.75%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Tarsus Pharmaceuticals (TARS) Stock Overview

    Tarsus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other diseases. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.

    TARS Stock Information

    Symbol
    TARS
    Address
    15440 Laguna Canyon RoadIrvine, CA 92618United States
    Founded
    -
    Trading hours
    9:30 AM - 4:00 PM ET
    Website
    https://www.tarsusrx.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    949 409 9820

    Tarsus Pharmaceuticals (TARS) Price Chart

    -
    Value:-

    Tarsus Pharmaceuticals Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $32.55
    N/A
    Market Cap
    $1.08B
    N/A
    Shares Outstanding
    33.10M
    N/A
    Employees
    87.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org